openPR Logo
Press release

Global Market Study on GMP Cell Banking Services Mammalian Cell Type Segment Revenue Projected to Grow 3.2x by 2025

MRRSE

MRRSE

Service providers in the global GMP cell banking services market are focusing on offering innovative services to retain market share. For instance, key players in the global GMP cell banking services market are focusing on the development of new and innovative service models and expanding the existing capacity. Providers are also adopting innovative marketing strategies to gain market share. Balancing fixed costs while offering competitive pricing is a major focus area for vendors in this market. For example, biopharmaceutical companies are focusing on outsourcing the manufacturing of biologics to the APAC region in order to reduce their manufacturing costs and thus set competitive pricing. Another strategy that key players are adopting in this market is increasing storage capacity and offering end-to-end services across all the nodes of the value chain. Companies are also entering into mergers and acquisitions as well as partnering with small biotech startups to expand service offerings, capacity and market presence globally.

Request For Sample Report : http://www.mrrse.com/sample/3098

In a new publication titled “GMP Cell Banking Services Market: Global Industry Analysis and Forecast, 2017–2025,” Persistence Market Research analysts have targeted five key geographies and have observed that North America represents the most lucrative market, followed by Europe and Asia Pacific. The GMP cell banking services market in MEA is expected to record comparatively less growth due to low awareness about these services and presence of limited manufacturing facilities.

The U.S. Food and Drug Administration guidance on contract manufacturing

The U.S. Food and Drug Administration issued its first guidance for quality agreements between pharmaceutical companies and CMOs in November 2016. The following is the regulatory overview of the FDA regarding contract manufacturing.

All manufacturing facilities to ensure compliance with cGMP regulations
Requirement of a quality unit in pharmaceutical companies to monitor adherence to regulations by a CMO
Various ICH guidelines have been published that are relevant to cGMP recommendations for contract manufacturing arrangements
Requirement of quality unit activities to be in writing
Report Description

The main focus of this report is on the process workflow of cell banking services. Various checkpoints are in place during the overall cell banking process to ensure quality and consistency of culture, as well as on avoiding contaminants. To make this report an exclusive one, the expert team of analysts have given an optimistic scenario, likely scenario and conservative scenario. The analysts have segmented the market into two main categories – cell type and end user – and have analyzed these segments across the assessed regions. The report executive summary succinctly covers the market overview, overall market approach, target geographies and differentiating strategies of the global GMP cell banking services market key players. The executive summary section is followed by the market introduction and consists of a thorough description of the various types of cells.

The report presents a detailed analysis of the GMP cell banking services market scenario. This analysis includes Y-o-Y growth and absolute $ opportunity analysis for the projected period. The market dynamics section focuses on the drivers, restraints, opportunities and trends likely to impact the global GMP cell banking services market. The analysts have made sure to cover each and every segment in detail along with highlighting the market share analysis, BPS analysis and the Y-o-Y growth rate of global GMP cell banking services. Finally, the report concludes with key player profiles accompanied by market developments, an overview of business strategies and SWOT analysis.

Market Segmentation

By Region

North America
Latin America
Europe
Asia Pacific
MEA
By Cell Type

Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others
By End User

Biopharmaceutical Companies
Contract Manufacturing Organizations
Research Methodology

The global GMP cell banking services market value is calculated based on the cell banks used to develop biopharmaceuticals. However, the analysts have excluded cord cell banking services that are not a part of GMP based cell banking services. Indicators such as R&D expenditure, research funding from government and non-profit organizations, etc. have been considered to arrive at the estimated market numbers. All information has been triangulated through validation of primary research data. Yearly change in inflation rate has not been factored in while forecasting market numbers. Top-down approach has been used to calculate the market sizing, while bottom-up approach by GMP cell bank types has been used to counter-validate the market estimations.

Browse Full Report With TOC : http://www.mrrse.com/gmp-cell-banking-service-market

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.   

State Tower 
90, State Street 
Suite 700 
Albany, NY - 12207 
United States
Telephone: +1-518-730-0559 
Email: sales@mrrse.com
Google+: https://plus.google.com/u/0/109558601025749677847/posts
Linked in: https://www.linkedin.com/company/mrrse
Twitter: https://twitter.com/MRRSEmrrse

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Market Study on GMP Cell Banking Services Mammalian Cell Type Segment Revenue Projected to Grow 3.2x by 2025 here

News-ID: 593938 • Views:

More Releases for GMP

Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides. As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EU
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp. This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008. “ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures. The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,